GSK's Fluarix Gets FDA Nod Under Accelerated Approval Process
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline expects to provide 8 mil. doses of its influenza vaccine for the 2005-2006 season.
You may also be interested in...
GSK’s Second Flu Vaccine Would Boost Capacity To 30 Mil. Doses
GSK submits a BLA for FluLaval, acquired as part of its 2005 purchase of ID Biomedical, to FDA March 23.
GSK’s Second Flu Vaccine Would Boost Capacity To 30 Mil. Doses
GSK submits a BLA for FluLaval, acquired as part of its 2005 purchase of ID Biomedical, to FDA March 23.
GSK To Gain Fluviral Vaccine Through Acquisition Of ID Biomedical
GlaxoSmithKline plans to acquire ID Biomedical for $1.4 bil., a deal that could provide GSK with a second flu vaccine in the U.S. for the 2006/2007 flu season.